Balloon Catheter Market Size, Share, Trends, Growth and Forecast Report by Product Type, Indication, Raw Material, End User, Countries and Company Analysis 2026-2034

Balloon Catheter Market Size & Forecast 2026-2034

The Balloon Catheter market is growing due to the rising incidences of cardiovascular and urological diseases, an increasing trend of minimally invasive medical procedures, and incessant technological upgrades. An expansion in medical infrastructure, along with a growing awareness level among medical practitioners and individuals, is also propelling the market forward. From an estimated value of US$ 4.86 billion in 2025, the global Balloon Catheter market is expected to grow to a value of US$ 8.77 billion by 2034, while rising by a CAGR of 6.78% from 2026 to 2034.

Balloon Catheter Market Outlook

Balloon catheter term refers to a flexible tube that may be employed to inflate a balloon near the tip to facilitate the widening of narrow or blocked body ducts and passageways. This catheter device has been common in carrying out procedures to widen narrowed or closed body passageways. It has been used to facilitate the flow of blood, to perform surgery in the heart and arteries, and also in the urology, gastroenterology, and gynecology fields of medicine. By expanding the balloons to the desired locations, it becomes easy to perform precise functions on the patients.

Balloon catheters have surged in popularity on a global scale owing to the increased acceptance of minimally invasive surgeries, which promise shorter recovery periods, shorter hospitalization stays, and fewer chances of complication. In addition to this, increases in the number of chronic illness cases, especially cardiovascular diseases, have played a crucial role in boosting demand for balloon catheter surgeries. Moreover, advancements in technology, for example, the introduction of drug-coated and high-pressure balloon catheters, have ensured increased efficiency of balloon catheters, promoting their effectiveness and safer use. Lastly, increases in healthcare facilities, awareness among patients, and access to modern medical treatment in emerging markets have boosted balloon catheter popularity and acceptance worldwide.

Growth Drivers of the Balloon Catheter Market

Rising Prevalence of Cardiovascular and Peripheral Vascular Diseases

The rise in cardiovascular and peripheral vascular diseases is one of the major growth drivers in the market for balloon catheters. With aging populations, sedentary lifestyles, obesity, and diabetes on the rise, the incidence of conditions like coronary artery disease, peripheral artery disease, and renal artery stenosis is also on the rise. Since balloon catheters are imperatively used in minimally invasive angioplasty procedures to restore blood flow in narrowed or blocked vessels, growing awareness of early intervention will increase procedure volumes and ensure improved access to interventional cardiology services around the world. Cardiovascular diseases continue to be among the leading causes of mortality, and hence, demand for balloon catheters has been consistently rising across hospitals and clinics. An approximate number of 19.8 million people died from CVDs in 2022, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke.

Shift Toward Minimally Invasive and Outpatient Procedures

The growth of the healthcare sector in terms of minimally invasive treatments is strongly responsible for the growth of the balloon catheter market. This is because balloon catheter-based angioplasty treatments help in minimizing recovery times, the rate of complications, and hospital stays when compared to traditional open-heart surgery. Therefore, minimally invasive treatments like balloon catheters are becoming common in healthcare institutions. With the healthcare sector emphasizing cost and patient efficiency considerations, the acceptance rate of minimally invasive treatments like balloon catheters is increasing in the market. Jan 2024 – Arthrex, the leading company in minimally invasive surgical technology and education in orthopaedic surgery skills, has now introduced a new and informative resource called TheNanoExperience.com that focuses on the science and benefits of Nano arthroscopy technology – a modern form of minimally invasive orthopaedic surgery that can reassure a quick return to activity and reduced pain.

Technological Advancements and Product Innovation

Continuous innovations, such as the ongoing developments taking place related to the improvement of the technology used in making balloon catheters, make this market prone to growth. To begin with, the continuous innovations that help take the market forward include the making of better materials, such as high-strength nylaons, semi-compliant material, and improved products, such as the scoring, the drug, or the improved shaft designs developed. Continuous improvement of products, such as the making of semi-compliant material, improves efficiency since one can execute the task better. Because the products that the industry offers are constantly improving, the efficiency that the products facilitate ensures continuous growth. May 2025, Boston Scientific Corporation (NYSE: BSX), today announced that the company has received CE Mark and FDA approval for its NC Quantum Apex PTCA Dilatation Balloon Catheter. Launch planned this week in European markets, next month in the US.

Challenges Faced by the Balloon Catheter Industry

Procedural Risks and Device-Related Complications

Currently, the balloon catheter industry is affected by several fundamental challenges. Firstly, balloon catheter use might result in various associated risks. There is always the risk of complications with angioplasty procedures. Complications might occur, for instance, through vessel dissection, vessel rupture, vessel restenosis, balloon rupture, etc. Using balloon catheters involves several risks, particularly in cases where lesions are either calcified. The risk might also result from improper balloon catheter selection. Complications, therefore, constitute some of the fundamental challenges being witnessed in the balloon catheter industry, particularly within the market.

Pricing Pressure and Reimbursement Constraints

It is observed that the prices of the product, i.e., the balloon catheter, undergo a strong pressure as a result of the competitive rivalry among players in the respective industry segment as well as the pricing pressures brought about through cost containment or reduction in healthcare services that tend to prove to be less favorable from the point of view of ensuring the incorporation of the latest technology in the category of balloon catheters that can prove more expensive for the healthcare facility in terms of costs of intervention procedures that might prove insufficient in terms of a proper reimbursement system in the country or region of consideration.

Normal Balloon Catheter Market

The normal balloon catheter market represents the most used segment for interventional cardiology and peripheral vascular procedures. These catheters are used mainly for balloon angioplasty, which stretches the narrowed or blocked blood vessels and allows proper blood circulation. Due to the simplicity of their design, cost-effectiveness, and ease of use, they represent the first choice for routine applications. Normal balloon catheters find their typical applications in coronary, peripheral, and renal interventions. The growing prevalence of cardiovascular diseases and the surging volumes of minimally invasive procedures continue to drive market demand. Hospitals and clinics around the world continue to use normal balloon catheters as first-line devices, ensuring steady growth across healthcare markets worldwide.

Scoring Balloon Catheter Market

The efficiency of the scoring balloon catheter in negotiating complex and calcified lesions has driven its market. Scoring balloon catheters have scoring elements or wires on the surface of the balloon that make controlled incisions in plaque during inflation of the balloon. Thus, they allow for more predictable vessel expansion and reduced risk of balloon slippage. Applications of scoring balloon catheters have been increasing in patients with resistant coronary or peripheral artery lesions. Increased adoption of advanced interventional techniques and improving clinical outcomes are promoting market growth. Clinicians are looking for more precise and effective approaches to overcome challenging cases; therefore, demand for scoring balloon catheters is increasing.

Balloon Catheter Coronary Artery Disease Market

The high prevalence of heart diseases globally propels the demand for a balloon catheter in treating coronary artery diseases. The intervention of percutaneous coronary primarily utilizes balloon catheters to dilate the vessels in cases where stenting will be performed. The incidence of lifestyle-associated cardiovascular diseases and ageing populations fuels higher procedural volumes. Evolution in technology, in terms of material and design, enhances safety and performance. Since coronary artery diseases remain one of the leading causes of mortality in the world, the balloon catheter remains of paramount importance in interventional cardiology.

Nylon Balloon Catheter Market

The market for nylon balloon catheters is driven by the strength and durability of the material along with controllable dilation. Moreover, by using a nylon balloon in catheters, a greater burst pressure can be achieved. Various studies suggest that the use of a nylon balloon in interventional cardiology has become common; hence, the market is driven by the increasing interest in more dependable and high-performance materials. With many manufacturers trying to improve the effectiveness of catheters in interventional cardiology and other procedures, the market size of nylon balloon catheters is significant.

Balloon Catheter Clinics Market

The market for balloon catheter clinics is witnessing growth due to the trend toward outpatient and minimally invasive procedures. The performance of angioplasty and diagnostic intervention using balloon catheters is increasingly being carried out in clinics and ambulatory care centers. This is because of shorter hospital stays, decreased cost, and quicker recoveries. A number of advanced catheter technologies are available at clinics, while skilled clinicians in these settings support the market. Clinics have become significant end users as health systems across the globe aim to provide efficient, cost-effective services.

United States Balloon Catheter Market

The United States market is the largest in the world, with a large prevalent base of cardiovascular diseases. It has an already highly developed interventional cardiology market, reflecting the large numbers of angioplasty, both coronary and peripheral, undertaken every year in the country. The country has highly sophisticated medical facilities, skilled medical personnel, and the acceptance of advanced technology in balloon catheters. The rising trend of choosing minimally invasive medical treatments continues to contribute to the market growth in the country. The relatively good insurance coverage of medical costs, particularly concerning minimally invasive medical devices, increases the competitiveness of the market in the country. The need to reduce the impact of CVDs on the world continues to drive the demand in the market in the country. Oct 2025 — Cagent Vascular has announced the launch of the Serranator PTA Serration Balloon Catheter in 7.0 mm and 8.0 mm diameters, expanding the range of the benefits of serration technology to treat larger vessel diseases, including the iliac, SFA, and other difficult peripheral diseased anatomy.

United Kingdom Balloon Catheter Market

The United Kingdom Balloon catheter market is driven by the increasing use of minimally invasive procedures for vascular as well as heart conditions, undertaken by the National Health Service. The increasing incidence of heart conditions, as well as an aging population, ensures an increasing requirement for angioplasty procedures. NHS initiatives towards shortening length of stay as well as boosting success of procedures help bolster growth. Further, technological advancements, combined with the availability of skilled interventional cardiologists, also favor the procedure. Even while various cost-controlling measures play an important part in the selection of medical devices, sustained investments in modern medical technologies favor the market. On the whole, it is expected that medical facilities in the UK will favor the usage of balloon catheters. September 2024 – CERENOVUS, Inc. announces the commercialization of its latest medical breakthrough, “EMBOGUARD,” a new generation of artifact-handling balloons for guide catheters used in endovascular treatments, including those for acute ischemic stroke.

India Balloon Catheter Market

Being a country with a nascent balloon catheter market in the medical industry, India’s balloon catheter market is expanding with an increase in medical conditions such as cardiovascular diseases. With rapid growth in the number of private medical centers and cardiologist availability, balloon catheters in this country are gaining popularity. In this country, healthcare is gaining more strength and will contribute to the balloon catheter market in the long term. In this country, with rapid growth in medical tourism and increasing availability of cardiologists, balloon catheters are expanding in this region with rapid growth in medical conditions and healthcare in this region. Jan 2025: Kossel Medtech launched Selethru® PTCA and Selethru® NC PTCA [Non-compliant] balloon dilatation catheters, which are approved by the CDSCO for treating coronary artery diseases.

Saudi Arabia Balloon Catheter Market

The growth of the balloon catheter market in Saudi Arabia will be propelled by an increasing burden of cardiovascular diseases and government investment in healthcare modernization under Vision 2030. The market is further boosted by the expansion of specialized cardiac centers and large-scale adoption of advanced medical technologies. Growing interest in minimally invasive procedures and increased accessibility to interventional cardiology services raise demand. While the market is highly dependent on imported devices, public–private partnerships and international collaborations are boosting technology adoption in the country. Driven by these factors, Saudi Arabia continues to upgrade its healthcare infrastructure and cardiac care-related competencies, thus fostering growth in the balloon catheter market. In March 2024, the Saudi Ministry of Health initiated a national cardiovascular screening program aiming at the early detection of arterial blockages in high-risk patients, further increasing the demand for advanced catheter-based interventions across all government hospitals. Such government-driven initiatives and policies are expected to drive business growth in the Middle East and Africa Balloon Catheter industry during the forecast period.